Methadone

Professor of Cannabis Science announced to research the role of cannabis in opioid overdose treatment

Retrieved on: 
Friday, November 23, 2018

Initially, this professorship will lead clinical trials to explore the role cannabis can play in helping people with opioid use disorder stay on their treatment plan.

Key Points: 
  • Initially, this professorship will lead clinical trials to explore the role cannabis can play in helping people with opioid use disorder stay on their treatment plan.
  • In the first nine months of 2018, it's estimated that 1,143 people died of a suspected opioid overdose in British Columbia.
  • This first-of-its-kind professorship will lead research and clinical trials on how cannabis products can be used to address the overdose crisis that is taking three to four lives a day."
  • Research shows that fewer than one-third of people who start opioid agonist therapy (OAT), with methadone or buprenorphine/naloxone, remain in treatment after six months.

Relmada Therapeutics to Present Clinical Data on the Effect of REL-1017 on BDNF Plasma Levels

Retrieved on: 
Tuesday, October 2, 2018

The study will enroll 60 subjects at approximately 10 sites in the United States.

Key Points: 
  • The study will enroll 60 subjects at approximately 10 sites in the United States.
  • In preclinical studies, REL-1017 showed antidepressant efficacy and effects on neuronal activity similar to that of ketamine.
  • The U.S. Food and Drug Administration previously granted Fast Track designation for dextromethadone for the adjunctive treatment of MDD.
  • Relmada undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

FAIR Health Releases State-by-State Visualizations of Opioid Abuse and Dependence

Retrieved on: 
Monday, October 1, 2018

The infographic includes the top five procedures associated with opioid abuse and dependence by utilization and aggregate cost, such as methadone administration, naltrexone injection and group psychotherapy.

Key Points: 
  • The infographic includes the top five procedures associated with opioid abuse and dependence by utilization and aggregate cost, such as methadone administration, naltrexone injection and group psychotherapy.
  • Each infographic also shows the percentages of opioid abuse and dependence diagnoses by age group and gender in the state.
  • FAIR Health President Robin Gelburd stated: "Our interactive heat map on opioid abuse and dependence opens a new geographic window into this serious epidemic.
  • FAIR Health stands ready to assist healthcare stakeholders with similar analytics and visualizations for other pressing public health concerns."

The Downtown Vancouver Business Improvement Association officially supports supervised consumption sites in the downtown core

Retrieved on: 
Thursday, May 10, 2018

VANCOUVER, May 10, 2018 /CNW/ -The Downtown Vancouver Business Improvement Association (DVBIA) announced today that they will officially support the establishment of supervised consumption sites within their 90-block district in the downtown core.

Key Points: 
  • VANCOUVER, May 10, 2018 /CNW/ -The Downtown Vancouver Business Improvement Association (DVBIA) announced today that they will officially support the establishment of supervised consumption sites within their 90-block district in the downtown core.
  • "The Downtown Vancouver Business Improvement Association is proud to officially lend our support to supervised consumption sites in to the downtown core."
  • "Supervised consumption sites save lives and prevent the spread of diseases among drug users and the general public.
  • Clientele of supervised consumption sites are also more likely to enroll in methadone maintenance or other drug treatment programs."